aibio
Debt Financing ·
Fresenius issues €1 billion in dual-tranche bonds
Two €500 million tranches, due in 2031 and 2034, will fund general corporate purposes, including refinancing.
FRE Firebrick Pharma Limited
Firebrick Pharma (FRE) news
Latest Firebrick Pharma news
We have not published a story on Firebrick Pharma yet. When there is news, it will appear here.
Questions about Firebrick Pharma
What is the ticker symbol of Firebrick Pharma?
Firebrick Pharma Limited trades under the ticker FRE on ASX.
Where is Firebrick Pharma listed?
Firebrick Pharma Limited is listed on ASX.
Which country or territory is Firebrick Pharma listed under?
Our directory records Firebrick Pharma Limited under Australia.
What does Firebrick Pharma do?
Our directory classifies Firebrick Pharma Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Firebrick Pharma?
The ISIN recorded for Firebrick Pharma Limited is AU0000197352.
Does aibio.space cover Firebrick Pharma?
aibio.space lists Firebrick Pharma Limited among 2,820 public biotech companies and publishes its news here as stories appear.
What is the latest Firebrick Pharma (FRE) stock news?
Our latest story on Firebrick Pharma, dated Jul 1, 2026: "Fresenius issues €1 billion in dual-tranche bonds". Two €500 million tranches, due in 2031 and 2034, will fund general corporate purposes, including refinancing. Source.
Does Firebrick Pharma have debt, a term loan or convertible notes?
Our latest debt story, dated Jul 1, 2026: "Fresenius issues €1 billion in dual-tranche bonds". Two €500 million tranches, due in 2031 and 2034, will fund general corporate purposes, including refinancing. Source.
Which companies are similar to Firebrick Pharma?
Companies in our directory listed in the same country and business area as Firebrick Pharma: Avecho Biotechnology, Mayne Pharma Group, Entropy Neurodynamics, Alterity Therapeutics, Vectus Biosystems, Biome Australia.
How can I follow Firebrick Pharma (FRE) news?
Press Follow on this page to add Firebrick Pharma to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Firebrick Pharma so far, in Debt Financing.
Investor discussion: Firebrick Pharma
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- Firebrick Pharma Limited
- Ticker
- FRE
- Listing
- ASX
- Country or territory
- Australia
- Business scope
- Pharmaceuticals: Major
- ISIN
- AU0000197352
- Last quote in directory
- 2026-10-22
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction